M&A / Deals Novo Nordisk and AWS form AI partnership to speed drug discovery PharmaTimesNew alliance aims to accelerate development of future medicinesRead full story pharminent August 17, 2026 (Last updated: August 18, 2026) PharmaTimes New alliance aims to accelerate development of future medicines Read full story Post navigation Previous: Sandoz targets industry patent void with $322m Henlius dealNext: J&J hands lymphoma bispecific CAR T back to AbelZeta Related Stories M&A / Deals Solstice Oncology secures $225m to drive porustobart’s development for cancer pharminent September 10, 2026 M&A / Deals UK’s Claret Capital raises 575m for European biotechs pharminent September 7, 2026 M&A / Deals GSK wagers up to $1.3B on a different kind of cancer drug pharminent September 3, 2026